| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.794 | 0.003 | 0.802 | Platelet adhesion inhibitor | 0.802 0.002 DBMET01403 0.785 0.003 DBMET02144 | DBMET01403 | |
| 0.623 | 0.005 | 0.774 | Platelet aggregation inhibitor | 0.774 0.004 DBMET01403 0.522 0.008 DBMET02144 | DBMET01403 | |
| 0.374 | 0.071 | 0.513 | Toll-Like receptor agonist | 0.513 0.029 DBMET01403 0.293 0.115 DBMET02144 | DBMET01403 | |
| 0.355 | 0.079 | 0.494 | Toll-Like receptor 7 agonist | 0.494 0.033 DBMET01403 0.259 0.14 DBMET02144 | DBMET01403 | |
| 0.265 | 0.002 | 0.434 | Prostacyclin agonist | 0.434 0.001 DBMET01403 0.254 0.002 DBMET02144 | DBMET01403 | |
| 0.31 | 0.049 | 0.516 | Platelet antagonist | 0.516 0.012 DBMET01403 0.461 0.018 DBMET02144 | DBMET01403 | |
| 0.298 | 0.049 | 0.485 | Vasodilator | 0.405 0.022 DBMET01403 0.485 0.013 DBMET02144 | DBMET02144 | |
| 0.278 | 0.066 | 0.278 | Cardiotonic | |||
| 0.159 | 0.029 | 0.159 | Interleukin 8 antagonist | 0.101 0.094 DBMET01403 | ||
| 0.114 | 0.003 | 0.312 | Prostaglandin D2 agonist | 0.312 0.002 DBMET01403 0.094 0.003 DBMET02144 | DBMET01403 | |
| 0.129 | 0.026 | 0.129 | Aminoacyl-tRNA synthetase inhibitor | 0.089 0.06 DBMET01403 | ||
| 0.096 | 0.004 | 0.096 | Cytokine production stimulant | 0.059 0.014 DBMET01403 0.088 0.005 DBMET02144 | ||
| 0.214 | 0.147 | 0.471 | Immunomodulator | 0.186 0.18 DBMET01403 0.471 0.028 DBMET02144 | DBMET02144 | |
| 0.169 | 0.105 | 0.169 | Interleukin antagonist | |||
| 0.082 | 0.019 | 0.082 | Prostaglandin E2 antagonist | |||
| 0.061 | 0.008 | 0.061 | Prostaglandin EP3 antagonist | |||
| 0.1 | 0.057 | 0.132 | Interleukin 1 beta converting enzyme inhibitor | 0.132 0.027 DBMET01403 | DBMET01403 | |
| 0.209 | 0.176 | 0.214 | Sodium/bile acid cotransporter inhibitor | 0.214 0.169 DBMET01403 | DBMET01403 | |
| 0.065 | 0.038 | 0.065 | Caspase 9 inhibitor | |||
| 0.05 | 0.032 | 0.05 | Urokinase inhibitor | |||
| 0.105 | 0.09 | 0.105 | MAP kinase 12 inhibitor | |||
| 0.095 | 0.081 | 0.095 | Factor V inhibitor | |||
| 0.076 | 0.063 | 0.076 | Adrenaline agonist | |||
| 0.035 | 0.025 | 0.035 | AMPA receptor agonist | |||
| 0.02 | 0.015 | 0.02 | Toll-Like receptor 8 agonist | 0.02 0.015 DBMET01403 | ||
| 0.014 | 0.015 | 0.023 | Cholecystokinin A agonist | 0.023 0.007 DBMET01403 | DBMET01403 | |
| 0.012 | 0.023 | 0.02 | Cholecystokinin agonist | 0.02 0.012 DBMET01403 | DBMET01403 | |
| 0.051 | 0.068 | 0.094 | Nitric oxide donor | 0.063 0.044 DBMET01403 0.094 0.012 DBMET02144 | DBMET02144 | |
| 0.073 | 0.09 | 0.174 | Aminopeptidase B inhibitor | 0.174 0.029 DBMET01403 | DBMET01403 | |
| 0.046 | 0.071 | 0.058 | Acetyl-CoA transferase 2 inhibitor | 0.058 0.036 DBMET01403 | DBMET01403 | |
| 0.081 | 0.117 | 0.102 | Folate antagonist | 0.102 0.061 DBMET01403 | DBMET01403 | |
| 0.017 | 0.06 | 0.032 | Liver X receptor alpha antagonist | 0.032 0.016 DBMET01403 | DBMET01403 | |
| 0.099 | 0.147 | 0.135 | Phospholipase A2 inhibitor | 0.135 0.093 DBMET01403 | DBMET01403 | |
| 0.012 | 0.073 | 0.057 | Prostacyclin antagonist | 0.057 0.01 DBMET01403 | DBMET01403 | |
| 0.137 | 0.204 | 0.345 | Hypoglycemic | 0.345 0.039 DBMET02144 | DBMET02144 | |
| 0.022 | 0.092 | 0.085 | Glutamate (mGluR1a) antagonist | 0.085 0.007 DBMET01403 | DBMET01403 | |
| 0.142 | 0.218 | 0.328 | Peptidyltransferase inhibitor | 0.187 0.118 DBMET01403 0.328 0.016 DBMET02144 | DBMET02144 | |
| 0.088 | 0.165 | 0.187 | Anticoagulant | 0.119 0.113 DBMET01403 0.187 0.058 DBMET02144 | DBMET02144 | |
| 0.109 | 0.203 | 0.569 | Immunostimulant | 0.318 0.074 DBMET01403 0.569 0.02 DBMET02144 | DBMET02144 | |
| 0.058 | 0.186 | 0.093 | Vanilloid agonist | 0.093 0.043 DBMET02144 | DBMET02144 | |
| 0.022 | 0.163 | 0.034 | Calcium-independent phospholipase A2 inhibitor | 0.034 0.023 DBMET01403 | DBMET01403 | |
| 0.103 | 0.246 | 0.186 | Phospholipase C inhibitor | 0.186 0.055 DBMET01403 0.138 0.134 DBMET02144 | DBMET01403 | |
| 0.007 | 0.155 | 0.03 | Prostaglandin agonist | 0.03 0.022 DBMET01403 | DBMET01403 | |
| 0.172 | 0.32 | 0.573 | Cyclophilin D inhibitor | 0.334 0.134 DBMET01403 0.573 0.032 DBMET02144 | DBMET02144 | |
| 0.03 | 0.186 | 0.09 | Aminopeptidase I inhibitor | 0.09 0.034 DBMET01403 | DBMET01403 | |
| 0.035 | 0.191 | 0.104 | Interferon inducer | 0.082 0.022 DBMET01403 0.104 0.011 DBMET02144 | DBMET02144 | |
| 0.127 | 0.29 | 0.586 | Antithrombotic | 0.335 0.07 DBMET01403 0.586 0.018 DBMET02144 | DBMET02144 | |
| 0.083 | 0.247 | 0.183 | Aldehyde oxidase inhibitor | 0.183 0.114 DBMET01403 | DBMET01403 | |
| 0.028 | 0.193 | 0.06 | Sphingosine 1-phosphate receptor 1 antagonist | 0.06 0.029 DBMET01403 | DBMET01403 | |
| 0.025 | 0.191 | 0.057 | Glucose-6-phosphate translocase inhibitor | 0.057 0.028 DBMET02144 | DBMET02144 | |
| 0.023 | 0.2 | 0.059 | Leukotriene synthesis inhibitor | 0.059 0.057 DBMET01403 | DBMET01403 | |
| 0.057 | 0.239 | 0.129 | Aldehyde dehydrogenase inhibitor | 0.129 0.063 DBMET01403 | DBMET01403 | |
| 0.007 | 0.209 | 0.025 | Liver X receptor beta antagonist | 0.025 0.024 DBMET01403 | DBMET01403 | |
| 0.021 | 0.224 | 0.116 | Phenylalanine 4-hydroxylase inhibitor | 0.116 0.019 DBMET01403 | DBMET01403 | |
| 0.075 | 0.279 | 0.121 | Vanilloid 1 agonist | 0.121 0.086 DBMET01403 0.112 0.109 DBMET02144 | DBMET01403 | |
| 0.031 | 0.238 | 0.127 | Interferon agonist | 0.101 0.028 DBMET01403 0.127 0.015 DBMET02144 | DBMET02144 | |
| 0.046 | 0.276 | 0.113 | Transcription factor NF kappa B stimulant | 0.113 0.029 DBMET02144 | DBMET02144 | |
| 0.032 | 0.267 | 0.073 | Sphingosine 1-phosphate receptor antagonist | 0.073 0.062 DBMET01403 | DBMET01403 | |
| 0.121 | 0.356 | 0.509 | Histamine release inhibitor | 0.46 0.045 DBMET01403 0.509 0.026 DBMET02144 | DBMET02144 | |
| 0.009 | 0.244 | 0.049 | Ornithine carbamoyltransferase inhibitor | 0.049 0.041 DBMET01403 | DBMET01403 | |
| 0.032 | 0.269 | 0.089 | Gastric antisecretory | 0.089 0.08 DBMET01403 | DBMET01403 | |
| 0.044 | 0.282 | 0.103 | Granulocyte macrophage colony stimulating factor agonist | 0.103 0.031 DBMET01403 | DBMET01403 | |
| 0.048 | 0.297 | 0.497 | Angiogenesis stimulant | 0.159 0.117 DBMET01403 0.497 0.012 DBMET02144 | DBMET02144 | |
| 0.11 | 0.358 | 0.221 | Insulysin inhibitor | 0.221 0.128 DBMET01403 | DBMET01403 | |
| 0.014 | 0.263 | 0.029 | Toll-Like receptor 4 agonist | 0.029 0.014 DBMET02144 | DBMET02144 | |
| 0.017 | 0.28 | 0.051 | Thromboxane synthase inhibitor | 0.051 0.045 DBMET01403 | DBMET01403 | |
| 0.047 | 0.311 | 0.157 | Photosensitizer | 0.142 0.036 DBMET01403 0.157 0.027 DBMET02144 | DBMET02144 | |
| 0.028 | 0.299 | 0.253 | Mediator release inhibitor | 0.206 0.014 DBMET01403 0.253 0.009 DBMET02144 | DBMET02144 | |
| 0.036 | 0.308 | 0.256 | Thrombolytic | 0.187 0.058 DBMET01403 0.256 0.032 DBMET02144 | DBMET02144 | |
| 0.017 | 0.29 | 0.077 | Porphobilinogen synthase inhibitor | 0.077 0.05 DBMET01403 | DBMET01403 | |
| 0.054 | 0.332 | 0.229 | Hypolipemic | 0.183 0.107 DBMET01403 0.229 0.078 DBMET02144 | DBMET02144 | |
| 0.006 | 0.284 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.01 DBMET02144 | DBMET02144 | |
| 0.013 | 0.297 | 0.041 | Neuraminidase (Influenza A) inhibitor | 0.041 0.04 DBMET02144 | DBMET02144 | |
| 0.01 | 0.304 | 0.062 | Sphingosine 1-phosphate receptor agonist | 0.062 0.015 DBMET01403 | DBMET01403 | |
| 0.03 | 0.338 | 0.11 | Acetylcholine muscarinic antagonist | 0.11 0.079 DBMET01403 | DBMET01403 | |
| 0.042 | 0.351 | 0.216 | Cell adhesion inhibitor | 0.138 0.054 DBMET01403 0.216 0.021 DBMET02144 | DBMET02144 | |
| 0.039 | 0.352 | 0.153 | Toll-Like receptor 4 antagonist | 0.153 0.019 DBMET02144 | DBMET02144 | |
| 0.029 | 0.349 | 0.131 | Cell adhesion molecule inhibitor | 0.082 0.051 DBMET01403 0.131 0.02 DBMET02144 | DBMET02144 | |
| 0.024 | 0.35 | 0.158 | DNA intercalator | 0.158 0.039 DBMET02144 | DBMET02144 | |
| 0.02 | 0.348 | 0.234 | Topoisomerase I inhibitor | 0.234 0.019 DBMET02144 | DBMET02144 | |
| 0.023 | 0.352 | 0.286 | Alkylator | 0.101 0.087 DBMET01403 0.286 0.013 DBMET02144 | DBMET02144 | |
| 0.033 | 0.369 | 0.16 | Amylase inhibitor | 0.16 0.059 DBMET02144 | DBMET02144 | |
| 0.024 | 0.366 | 0.098 | Nitric-oxide synthase inhibitor | 0.098 0.063 DBMET01403 | DBMET01403 | |
| 0.018 | 0.378 | 0.119 | Alcohol dehydrogenase inhibitor | 0.119 0.035 DBMET01403 | DBMET01403 | |
| 0.027 | 0.388 | 0.148 | Protein-tyrosine phosphatase inhibitor | 0.148 0.081 DBMET01403 | DBMET01403 | |
| 0.011 | 0.381 | 0.055 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.053 0.043 DBMET01403 0.055 0.041 DBMET02144 | DBMET02144 | |
| 0.047 | 0.421 | 0.385 | Hemostatic | 0.189 0.037 DBMET01403 0.385 0.009 DBMET02144 | DBMET02144 | |
| 0.059 | 0.44 | 0.465 | Immunosuppressant | 0.209 0.188 DBMET01403 0.465 0.043 DBMET02144 | DBMET02144 | |
| 0.068 | 0.456 | 0.196 | Gastrin inhibitor | 0.196 0.154 DBMET01403 | DBMET01403 | |
| 0.111 | 0.5 | 0.656 | Antiinflammatory | 0.656 0.039 DBMET02144 | DBMET02144 | |
| 0.041 | 0.431 | 0.119 | Interleukin 4 antagonist | 0.119 0.087 DBMET02144 | DBMET02144 | |
| 0.009 | 0.406 | 0.288 | Selectin antagonist | 0.288 0.006 DBMET02144 | DBMET02144 | |
| 0.013 | 0.411 | 0.09 | Inducible nitric-oxide synthase inhibitor | 0.09 0.048 DBMET01403 | DBMET01403 | |
| 0.076 | 0.476 | 0.474 | Vasodilator, coronary | 0.25 0.134 DBMET01403 0.474 0.019 DBMET02144 | DBMET02144 | |
| 0.011 | 0.421 | 0.063 | Neuraminidase (influenza) inhibitor | 0.063 0.047 DBMET02144 | DBMET02144 | |
| 0.024 | 0.437 | 0.169 | Lipid peroxidase inhibitor | 0.169 0.056 DBMET02144 | DBMET02144 | |
| 0.024 | 0.442 | 0.064 | Adenine nucleotide translocase inhibitor | 0.064 0.021 DBMET02144 | DBMET02144 | |
| 0.035 | 0.458 | 0.187 | Peroxidase inhibitor | 0.187 0.063 DBMET01403 | DBMET01403 | |
| 0.031 | 0.454 | 0.098 | Acetylcholine release stimulant | 0.098 0.093 DBMET02144 | DBMET02144 | |
| 0.03 | 0.461 | 0.147 | Insulin sensitizer | 0.147 0.137 DBMET01403 | DBMET01403 | |
| 0.082 | 0.516 | 0.125 | CC chemokine 6 receptor antagonist | 0.125 0.093 DBMET02144 | DBMET02144 | |
| 0.074 | 0.523 | 0.238 | GABA C receptor rho-3 antagonist | 0.238 0.166 DBMET01403 | DBMET01403 | |
| 0.016 | 0.473 | 0.226 | Psychostimulant | 0.226 0.067 DBMET01403 0.165 0.103 DBMET02144 | DBMET01403 | |
| 0.036 | 0.496 | 0.106 | Adenylate kinase inhibitor | 0.106 0.059 DBMET01403 | DBMET01403 | |
| 0.032 | 0.495 | 0.331 | Antiamyloidogenic | 0.331 0.043 DBMET02144 | DBMET02144 | |
| 0.025 | 0.488 | 0.115 | Toll-Like receptor 2 antagonist | 0.115 0.084 DBMET01403 | DBMET01403 | |
| 0.05 | 0.516 | 0.229 | Superoxide dismutase inhibitor | 0.229 0.089 DBMET01403 | DBMET01403 | |
| 0.035 | 0.501 | 0.241 | Succinate dehydrogenase inhibitor | 0.241 0.025 DBMET01403 | DBMET01403 | |
| 0.061 | 0.529 | 0.147 | Neurotensin receptor agonist | 0.147 0.109 DBMET01403 | DBMET01403 | |
| 0.027 | 0.497 | 0.054 | Lipocortins synthesis agonist | 0.054 0.051 DBMET02144 | DBMET02144 | |
| 0.058 | 0.53 | 0.144 | Lipocortins synthesis antagonist | 0.144 0.115 DBMET01403 | DBMET01403 | |
| 0.029 | 0.501 | 0.371 | Free radical scavenger | 0.371 0.034 DBMET02144 | DBMET02144 | |
| 0.079 | 0.56 | 0.184 | Tyrosine 3 hydroxylase inhibitor | 0.184 0.167 DBMET01403 | DBMET01403 | |
| 0.039 | 0.523 | 0.402 | DNA damaging | 0.191 0.123 DBMET01403 0.402 0.028 DBMET02144 | DBMET02144 | |
| 0.041 | 0.535 | 0.292 | Hepatoprotectant | 0.292 0.032 DBMET02144 | DBMET02144 | |
| 0.02 | 0.515 | 0.113 | Multidrug resistance-associated protein 1 inhibitor | 0.113 0.058 DBMET02144 | DBMET02144 | |
| 0.004 | 0.504 | 0.063 | Glutamate (mGluR1) antagonist | 0.063 0.036 DBMET01403 | DBMET01403 | |
| 0.012 | 0.515 | 0.05 | Antibiotic Aminoglycoside-like | 0.05 0.013 DBMET02144 | DBMET02144 | |
| 0.079 | 0.599 | 0.402 | Interleukin 2 agonist | 0.202 0.186 DBMET01403 0.402 0.027 DBMET02144 | DBMET02144 | |
| 0.008 | 0.541 | 0.056 | Aconitate hydratase inhibitor | 0.056 0.03 DBMET01403 | DBMET01403 | |
| 0.027 | 0.562 | 0.168 | Cyclooxygenase 3 inhibitor | 0.105 0.095 DBMET01403 0.168 0.034 DBMET02144 | DBMET02144 | |
| 0.007 | 0.545 | 0.058 | Alpha-mannosidase inhibitor | 0.058 0.03 DBMET02144 | DBMET02144 | |
| 0.012 | 0.561 | 0.123 | Mucolytic | 0.123 0.051 DBMET01403 | DBMET01403 | |
| 0.009 | 0.562 | 0.079 | Protein 50S ribosomal subunit inhibitor | 0.079 0.02 DBMET02144 | DBMET02144 | |
| 0.026 | 0.579 | 0.158 | Insulin secretagoues | 0.158 0.066 DBMET02144 | DBMET02144 | |
| 0.064 | 0.633 | 0.343 | 5 Hydroxytryptamine release inhibitor | 0.343 0.122 DBMET01403 0.294 0.172 DBMET02144 | DBMET01403 | |
| 0.011 | 0.581 | 0.069 | Topoisomerase II alpha inhibitor | 0.069 0.063 DBMET02144 | DBMET02144 | |
| 0.005 | 0.581 | 0.047 | Mannosidase inhibitor | 0.047 0.029 DBMET02144 | DBMET02144 | |
| 0.01 | 0.586 | 0.141 | Topoisomerase II inhibitor | 0.141 0.054 DBMET02144 | DBMET02144 | |
| 0.008 | 0.585 | 0.199 | Expectorant | 0.098 0.071 DBMET01403 0.199 0.021 DBMET02144 | DBMET02144 | |
| 0.016 | 0.594 | 0.115 | Alpha-N-acetylglucosaminidase inhibitor | 0.115 0.083 DBMET02144 | DBMET02144 | |
| 0.013 | 0.598 | 0.163 | Beta amyloid protein antagonist | 0.163 0.032 DBMET02144 | DBMET02144 | |
| 0.02 | 0.614 | 0.12 | NADH dehydrogenase inhibitor | 0.12 0.028 DBMET02144 | DBMET02144 | |
| 0.062 | 0.666 | 0.429 | Caspase 9 stimulant | 0.283 0.213 DBMET01403 0.429 0.095 DBMET02144 | DBMET02144 | |
| 0.028 | 0.661 | 0.26 | Interleukin agonist | 0.26 0.072 DBMET02144 | DBMET02144 | |
| 0.004 | 0.642 | 0.043 | Microtubule stabilization | 0.043 0.037 DBMET02144 | DBMET02144 | |
| 0.038 | 0.699 | 0.512 | Apoptosis agonist | 0.512 0.071 DBMET02144 | DBMET02144 | |
| 0.007 | 0.696 | 0.056 | Heparanase inhibitor | 0.056 0.031 DBMET02144 | DBMET02144 | |
| 0.003 | 0.71 | 0.108 | Monophenol monooxygenase inhibitor | 0.108 0.07 DBMET02144 | DBMET02144 | |
| 0.012 | 0.721 | 0.395 | Antioxidant | 0.395 0.036 DBMET02144 | DBMET02144 | |
| 0.017 | 0.727 | 0.215 | Tumour necrosis factor alpha release inhibitor | 0.215 0.096 DBMET02144 | DBMET02144 | |
| 0.02 | 0.741 | 0.362 | Cholesterol antagonist | 0.204 0.161 DBMET01403 0.362 0.06 DBMET02144 | DBMET02144 | |
| 0.009 | 0.738 | 0.17 | Spasmolytic | 0.17 0.145 DBMET02144 | DBMET02144 | |
| 0.009 | 0.741 | 0.092 | UDP-glucose 4-epimerase inhibitor | 0.092 0.071 DBMET02144 | DBMET02144 | |
| 0.02 | 0.759 | 0.135 | Interferon gamma antagonist | 0.135 0.101 DBMET02144 | DBMET02144 | |
| 0.003 | 0.744 | 0.093 | Antineoplastic antibiotic | 0.093 0.049 DBMET02144 | DBMET02144 | |
| 0.032 | 0.79 | 0.361 | Apoptosis antagonist | 0.209 0.168 DBMET01403 0.361 0.051 DBMET02144 | DBMET02144 | |
| 0.011 | 0.772 | 0.325 | DNA synthesis inhibitor | 0.325 0.036 DBMET02144 | DBMET02144 | |
| 0.019 | 0.794 | 0.28 | Vasodilator, peripheral | 0.28 0.107 DBMET01403 0.21 0.165 DBMET02144 | DBMET01403 | |
| 0.01 | 0.793 | 0.119 | Protein kinase stimulant | 0.119 0.094 DBMET02144 | DBMET02144 | |
| 0.01 | 0.798 | 0.151 | Cell wall synthesis inhibitor | 0.151 0.065 DBMET02144 | DBMET02144 | |
| 0.009 | 0.801 | 0.465 | Transcription factor NF kappa B inhibitor | 0.465 0.05 DBMET02144 | DBMET02144 | |
| 0.007 | 0.863 | 0.218 | Nitric oxide antagonist | 0.218 0.061 DBMET02144 | DBMET02144 | |
| 0.005 | 0.894 | 0.515 | Antibacterial | 0.515 0.036 DBMET02144 | DBMET02144 | |
| 0.022 | 0.919 | 0.131 | NOS3 expression enhancer | 0.131 0.096 DBMET02144 | DBMET02144 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |